Status:
COMPLETED
Proteomic Analysis Reveals Innate Immune Activity In Intestinal Transplant Dysfunction
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
NIH T32 Human and Molecular Development Training Grant
Conditions:
Intestinal Transplant
Cellular Rejection
Eligibility:
All Genders
Brief Summary
Many patients with intestinal failure require intestinal transplantation for survival. Currently, the gold standard for diagnosing acute cellular rejection (ACR) is histological examination of endosco...
Detailed Description
INTRODUCTION: Intestinal transplantation (ITx) offers a potential means of survival for patients with intestinal failure who have developed life threatening complications. Approximately 200 ITx proce...
Eligibility Criteria
Inclusion
- Intestinal transplant recipient
- Less than 8 weeks post transplant
Exclusion
- Intestinal transplant recipients more than 8 weeks post transplant
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT01140152
Start Date
July 1 2008
End Date
September 1 2009
Last Update
June 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA
Los Angeles, California, United States, 90095